Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route
Butong Sun, Nanjun Hu, Dan Cong, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 3219-3228
Open Access | Times Cited: 24

Showing 24 citing articles:

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway
Yitian Dai, Yuping Liu, Jingyi Li, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13906-13918
Open Access | Times Cited: 48
MicroRNAs as important players in regulating cancer through PTEN/PI3K/AKT signalling pathways
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Durairaj Sekar
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188904-188904
Closed Access | Times Cited: 32
The role of selected non-coding RNAs in the biology of non-small cell lung cancer
Kajetan Kiełbowski, Konrad Ptaszyński, Janusz Wójcik, et al.
Advances in Medical Sciences (2023) Vol. 68, Iss. 1, pp. 121-137
Open Access | Times Cited: 26
The regulatory role of autophagy-related miRNAs in lung cancer drug resistance
Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112735-112735
Open Access | Times Cited: 34
Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer
Radu Pîrlog, Paul Chiroi, Ioana Rusu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5346-5346
Open Access | Times Cited: 30
Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death
Feng Shi, Luquan Zhang, Xing Liu, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6332-6342
Open Access | Times Cited: 28
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
Yuxin Zhao, Haiyong Wang, Chengwei He
Journal of Cancer Research and Clinical Oncology (2021) Vol. 147, Iss. 12, pp. 3653-3664
Closed Access | Times Cited: 26
RETRACTED ARTICLE: Circ_0017639 facilitates proliferative, migratory, and invasive potential of non-small cell lung cancer (NSCLC) cells via PI3K/AKT signaling pathway
Hongbo Zhang, Xiang-Ming Qiu, Yichao Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 1, pp. 1590-1601
Open Access | Times Cited: 18
Anesthetic propofol enhances cisplatin-sensitivity of non-small cell lung cancer cells through N6-methyladenosine-dependently regulating the miR-486-5p/RAP1-NF-κB axis
Quan Ling, Shaoyong Wu, Xiaozu Liao, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC): Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment
Francesco Nucera, Paolo Ruggeri, Calogera Claudia Spagnolo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6685-6685
Open Access | Times Cited: 3
Mechanistic and therapeutic perspectives of miRNA-PTEN signaling axis in cancer therapy resistance
Di Wu, Chunjie Huang, Kaifeng Guan
Biochemical Pharmacology (2024) Vol. 226, pp. 116406-116406
Closed Access | Times Cited: 3
Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
Pía Loren, Nicolás Saavedra, Kathleen Saavedra, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer
Yanting Wang, Tao Zhang, Xin He
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
MicroRNA‐577/EIF5A2 axis suppressed the proliferation of DDP‐resistant nasopharyngeal carcinoma cells by blocking TGF‐β signaling pathway
Renrui Wu, Qiong Zhong, Huafeng Liu, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 4, pp. 815-827
Closed Access | Times Cited: 6
Circ_0102231 inactivates the PI3K/AKT signaling pathway by regulating the miR‐635/NOVA2 pathway to promote the progression of non‐small cell lung cancer
Jianhong Liu, Qiong Yu, Xu Yang
Thoracic Cancer (2023) Vol. 14, Iss. 35, pp. 3453-3464
Open Access | Times Cited: 5
The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer
Michał Szczyrek, Paulina Bitkowska, Marta Jutrzenka, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1227-1227
Open Access | Times Cited: 9
MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt
Yupeng Chen, Lin Wu, Min Bao
Molecular Biotechnology (2022) Vol. 65, Iss. 5, pp. 794-806
Closed Access | Times Cited: 7
Plk3 Enhances Cisplatin Sensitivity of Nonsmall-Cell Lung Cancer Cells through Inhibition of the PI3K/AKT Pathway via Stabilizing PTEN
Mengshan Xu, Xiaoyun Deng, Nana Xiang, et al.
ACS Omega (2024) Vol. 9, Iss. 8, pp. 8995-9002
Open Access | Times Cited: 1
Long non-coding RNA LINC00958 promotes colorectal cancer progression by enhancing the expression of LEM domain containing 1 via microRNA miR-3064-5p
Zhaoxia Luo, Shunxin Hao, Jian Yuan, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 8100-8115
Open Access | Times Cited: 9
A comprehension of signaling pathways and drug resistance; an insight into the correlation between microRNAs and cancer
Hashem O. Alsaab, Bekhzod Abdullaev, Adnan Taan Alkhafaji, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154848-154848
Open Access | Times Cited: 3
Lysosomal activable Vorinostat carrier-prodrug self-assembling with BPQDs enables photothermal oncotherapy to reverse tumor thermotolerance and metastasis
Yingjie Yu, Bingkai Wang, Miao Sun, et al.
International Journal of Pharmaceutics (2022) Vol. 617, pp. 121580-121580
Closed Access | Times Cited: 4
CircRNA B cell linker regulates cisplatin sensitivity in nonsmall cell lung cancer via microRNA-25-3p/BarH‑like homeobox 2 axis
Yi Liu, Yirong Hu, Chong Zhao, et al.
Anti-Cancer Drugs (2023)
Closed Access | Times Cited: 1
Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression
Jing Zhang, Xiaohai Cui, Hangying Qu, et al.
Journal of Chemotherapy (2023) Vol. 35, Iss. 6, pp. 550-562
Closed Access
Page 1

Scroll to top